Parkinson's Disease News and Research RSS Feed - Parkinson's Disease News and Research Twitter

Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Experimental drug may prevent development of multiple sclerosis in mice

Experimental drug may prevent development of multiple sclerosis in mice

The experimental drug laquinimod may prevent the development or reduce the progression of multiple sclerosis (MS) in mice, according to research published in the September 21, 2016, online issue of Neurology Neuroimmunology & Neuroinflammation, a medical journal of the American Academy of Neurology. [More]
Enzyme deficiency in Krabbe's disease may point to new mechanisms underlying Parkinson's disease

Enzyme deficiency in Krabbe's disease may point to new mechanisms underlying Parkinson's disease

A new article suggests that an enzyme deficiency seen in the lysosomal storage disorder Krabbe's disease may point to new mechanisms underlying certain late-onset neurodegenerative diseases such as Parkinson's disease. [More]
Study provides deeper understanding of how cells' crowded surfaces induce complex protein behavior

Study provides deeper understanding of how cells' crowded surfaces induce complex protein behavior

Scientists at The Scripps Research Institute have brought physics and biology together to further understand how cells' crowded surfaces induce complex protein behavior. [More]
Women, minorities less likely to receive stroke treatment, study finds

Women, minorities less likely to receive stroke treatment, study finds

Women and minorities may be less likely to receive treatment for stroke, according to a study published in the September 14, 2016, online issue of Neurology®, the medical journal of the American Academy of Neurology. [More]
Real-time MRI guidance could help target and deliver stem cell therapies

Real-time MRI guidance could help target and deliver stem cell therapies

Working with animals, a team of scientists reports it has delivered stem cells to the brain with unprecedented precision by threading a catheter through an artery and infusing the cells under real-time MRI guidance. [More]
International conference on longevity to be held in Brussels for 3 days

International conference on longevity to be held in Brussels for 3 days

The Eurosymposium on Healthy Ageing is an international event that provides a unique opportunity for researchers, government officials, biotech executives, entrepreneurs, and non-governmental institutions from around the world to meet, network, and forge new scientific collaborations. [More]
Clinical trial to examine effectiveness of diabetes drug to slow or stop progression of Parkinson's

Clinical trial to examine effectiveness of diabetes drug to slow or stop progression of Parkinson's

Type II diabetes and Parkinson's disease may not appear to have much in common but a look below the surface reveals important molecular similarities that provide a potential target for fighting Parkinson's. [More]
Different types of stroke have diverse risk profiles in overweight or obese women

Different types of stroke have diverse risk profiles in overweight or obese women

According to new research, women who are overweight or obese may have an increased risk of the most common kind of stroke, called ischemic stroke, but a decreased risk of a more often deadly stroke, called hemorrhagic stroke. [More]
New PET scan can detect prostate cancer earlier than MRIs and CT scans

New PET scan can detect prostate cancer earlier than MRIs and CT scans

Loyola Medicine is the first center in the Midwest to offer the first effective PET/CT scan for prostate cancer patients. [More]
Researchers use unique computational approach to identify promising drug leads for heart diseases

Researchers use unique computational approach to identify promising drug leads for heart diseases

Using a unique computational approach to rapidly sample, in millisecond time intervals, proteins in their natural state of gyrating, bobbing, and weaving, a research team from UC San Diego and Monash University in Australia has identified promising drug leads that may selectively combat heart disease, from arrhythmias to cardiac failure. [More]
Scientists developing virtual reality-based early diagnosis system for neurodegenerative disorders

Scientists developing virtual reality-based early diagnosis system for neurodegenerative disorders

Scientists from Tomsk Polytechnic University and Siberian State Medical University are developing an early diagnosis system for neurodegenerative disorders. [More]
Monoclonal antibody removes brain amyloid plaques in patients with Alzheimer's disease

Monoclonal antibody removes brain amyloid plaques in patients with Alzheimer's disease

Scientists at Neurimmune today described results from the Phase 1b PRIME clinical trial of the monoclonal antibody aducanumab. [More]
Research reveals new insights into happy hormone, dopamine

Research reveals new insights into happy hormone, dopamine

Dopamine is a so-called messenger substance or neurotransmitter that conveys signals between neurons. [More]
Taking two new epilepsy drugs during pregnancy may not harm thinking skills and IQs of children

Taking two new epilepsy drugs during pregnancy may not harm thinking skills and IQs of children

Two epilepsy drugs, levetiracetam and topiramate, may not harm the thinking skills and IQs of school-age children born to women who took them while pregnant, according to a recent study. [More]
Whitehead Institute scientists develop novel method for profiling mitochondrial metabolites

Whitehead Institute scientists develop novel method for profiling mitochondrial metabolites

Whitehead Institute scientists have developed a method to quickly isolate and systematically measure metabolite concentrations within the cellular organelles known as mitochondria, often referred to as the "powerhouses of the cell." [More]
New test may help detect Parkinson's disease in early stages of illness

New test may help detect Parkinson's disease in early stages of illness

A test that can detect Parkinson's disease in the early stages of the illness has moved a step closer. [More]
MRI-guided focused ultrasound treatment improves quality of life in patients with essential tremor

MRI-guided focused ultrasound treatment improves quality of life in patients with essential tremor

Treatment with MRI-guided focused ultrasound significantly improves tremors and quality of life in patients with essential tremor (ET), the most common movement disorder, according to a study published in the August 25 issue of the New England Journal of Medicine. [More]
High-tech alternative to brain surgery safe, effective for treatment of essential tremor

High-tech alternative to brain surgery safe, effective for treatment of essential tremor

A study published today in the prestigious New England Journal of Medicine offers the most in-depth assessment yet of the safety and effectiveness of a high-tech alternative to brain surgery to treat the uncontrollable shaking caused by the most common movement disorder. [More]
People with high levels of four biomarkers may have increased risk for stroke

People with high levels of four biomarkers may have increased risk for stroke

People with high levels of four biomarkers in the blood may be more likely to develop a stroke than people with low levels of the biomarkers, according to a study published in the August 24, 2016, online issue of Neurology, the medical journal of the American Academy of Neurology. [More]
Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Raising brain protein alleviates symptoms of Alzheimer's disease in mouse model

Boosting levels of a specific protein in the brain alleviates hallmark features of Alzheimer's disease in a mouse model of the disorder, according to new research published online August 25, 2016 in Scientific Reports. [More]
Advertisement
Advertisement